A recent study using CRISPR/Cas9-mediated in vivo EML4-ALK engineering in mice also showed that the mice expressing EML4-ALK were born with lung cancer, indicating that EML4-ALK is definitely a strong cancer promoter and a good therapeutic target [25]. This evidence concerns the gene ALK and lung carcinoma.